WHO ICTRP trial
Doppelblinde, randomisierte, Placebo-kontrollierte Studie der Phase III zur…
EUCTR2008-007053-13-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-007053-13-DE |
|---|---|
| Public title | Doppelblinde, randomisierte, Placebo-kontrollierte Studie der Phase III zur Bestimmung der Wirksamkeit, Verträglichkeit und Sicherheit von intravesikal verabreichter Oxybutynin-Lösung bei Kindern/Jugendlichen mit neurogen bedingter Detrusorhyperaktivität |
| Scientific title | Doppelblinde, randomisierte, Placebo-kontrollierte Studie der Phase III zur Bestimmung der Wirksamkeit, Verträglichkeit und Sicherheit von intravesikal verabreichter Oxybutynin-Lösung bei Kindern/Jugendlichen mit neurogen bedingter Detrusorhyperaktivität |
| Primary sponsor | Grachtenhaus-Apotheke, Inh. Klaus Stegemann e. K. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | bladder disorder (detrusor hyperactivity caused by neurogenic disorder) MedDRA version: 9.1 Level: LLT Classification code 10061011 Term: |
| Interventions | Product Name: Oxybutynin 0.052% Grachtenhaus Pharmaceutical Form: Solution for intravesical use INN or Proposed INN: Oxybutynin hydrochloride CAS Number: 1508652 Concentration unit: % (W/W) percent weight/weight Concentration type: equal… |
| Registration date | Mar 6, 2009 |
| Secondary IDs | STEG-CORP_111802 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: